Short bowel syndrome and intestinal failure in Crohn's disease

Inflammatory Bowel Diseases

Volumn 22, Issue 5, 2016, Pages 1209-1218

  Limketkai, Berkeley N ^a,b   Parian, Alyssa M ^b   Shah, Neha D ^a   Colombel, Jean Frédéric ^c  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Crohn's Disease; enteral nutrition; intestinal failure; nutrition support; parenteral nutrition; short bowel syndrome

Indexed keywords

ANTIDIARRHEAL AGENT; CLONIDINE; GLUCAGON LIKE PEPTIDE 2; GROWTH HORMONE; OCTREOTIDE; TRACE ELEMENT;

AGE; BLOODSTREAM INFECTION; CATHETER INFECTION; CHOLELITHIASIS; COMORBIDITY; CROHN DISEASE; DIETITIAN; ENTERIC FEEDING; FAMILY HISTORY; HUMAN; HYPERTENSION; INTESTINAL DYSMOTILITY; INTESTINAL FAILURE; INTESTINE TRANSPLANTATION; MALABSORPTION; META ANALYSIS (TOPIC); METABOLIC BONE DISEASE; MORTALITY; NEPHROLITHIASIS; NUTRITIONAL DEFICIENCY; NUTRITIONAL SUPPORT; PARENTERAL NUTRITION; PATHOPHYSIOLOGY; PEROPERATIVE COMPLICATION; PHASE 3 CLINICAL TRIAL (TOPIC); PHENOTYPE; PHYSICIAN; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; SHORT BOWEL SYNDROME; SMALL INTESTINE; SURFACE AREA; ANIMAL; COMPLICATION; INTESTINE; RISK FACTOR;

ANIMALS; CROHN DISEASE; HUMANS; INTESTINES; RISK FACTORS; SHORT BOWEL SYNDROME;

EID: 84964889404     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1097/MIB.0000000000000698     Document Type: Review

References (100)

1. Bernell O, Lapidus A, Hellers G. Risk factors for surgery and postoperative recurrence in Crohn's disease. Ann Surg. 2000; 231: 38-45
2. Peyrin-Biroulet L, Harmsen WS, Tremaine WJ, et al. Surgery in a population- based cohort of Crohn's disease from Olmsted County, Minnesota (1970-2004). Am J Gastroenterol. 2012; 107: 1693-1701
3. Fornaro R, Caratto E, Caratto M, et al. Post-operative recurrence in Crohn's disease. Critical analysis of potential risk factors. An update. Surgeon. 2015; 13: 330-347
4. Howard L, Ament M, Fleming CR, et al. Current use and clinical outcome of home parenteral and enteral nutrition therapies in the United States. Gastroenterology. 1995; 109: 355-365
5. Bakker H, Bozzetti F, Staun M, et al. Home parenteral nutrition in adults: a european multicentre survey in 1997. ESPEN-Home Artificial Nutrition Working Group. Clin Nutr. 1999; 18: 135-140
6. Howard L, Heaphey L, Fleming CR, et al. Four years of North American registry home parenteral nutrition outcome data and their implications for patient management. JPEN J Parenter Enteral Nutr. 1991; 15: 384-393
7. Lloyd DA, Vega R, Bassett P, et al. Survival and dependence on home parenteral nutrition: experience over a 25-year period in a UK referral centre. Aliment Pharmacol Ther. 2006; 24: 1231-1240
8. Scott NA, Leinhardt DJ, O'Hanrahan T, et al. Spectrum of intestinal failure in a specialised unit. Lancet. 1991; 337: 471-473
9. Lal S, Teubner A, Shaffer JL. Review article: intestinal failure. Aliment Pharmacol Ther. 2006; 24: 19-31
10. Limketkai BN, Orandi B, Luo X, et al. Intestinal transplantation for Crohn's disease: a 5-year nationwide follow-up. Gastroenterology. 2015; 148: S241
11. Dias CC, Rodrigues PP, da Costa-Pereira A, et al. Clinical prognostic factors for disabling Crohn's disease: a systematic review and metaanalysis. World J Gastroenterol. 2013; 19: 3866-3871
12. Loly C, Belaiche J, Louis E. Predictors of severe Crohn's disease. Scand J Gastroenterol. 2008; 43: 948-954
13. Beaugerie L, Seksik P, Nion-Larmurier I, et al. Predictors of Crohn's disease. Gastroenterology. 2006; 130: 650-656
14. Cosnes J, Beaugerie L, Carbonnel F, et al. Smoking cessation and the course of Crohn's disease: an intervention study. Gastroenterology. 2001; 120: 1093-1099
15. Elriz K, Palascak-Juif V, Joly F, et al. Crohn's disease patients with chronic intestinal failure receiving long-Term parenteral nutrition: a cross-national adult study. Aliment Pharmacol Ther. 2011; 34: 931-940
16. Gearry RB, Kamm MA, Hart AL, et al. Predictors for developing intestinal failure in patients with Crohn's disease. J Gastroenterol Hepatol. 2013; 28: 801-807
17. Uchino M, Ikeuchi H, Bando T, et al. Risk factors for short bowel syndrome in patients with Crohn's disease. Surg Today. 2012; 42: 447-452
18. Thompson JS, Iyer KR, DiBaise JK, et al. Short bowel syndrome and Crohn's disease. J Gastrointest Surg. 2003; 7: 1069-1072
19. Messing B, Crenn P, Beau P, et al. Long-Term survival and parenteral nutrition dependence in adult patients with the short bowel syndrome. Gastroenterology. 1999; 117: 1043-1050
20. Watanabe K, Sasaki I, Fukushima K, et al. Long-Term incidence and characteristics of intestinal failure in Crohn's disease: a multicenter study. J Gastroenterol. 2014; 49: 231-238
21. Yamamoto T, Allan RN, Keighley MR. Risk factors for intra-Abdominal sepsis after surgery in Crohn's disease. Dis Colon Rectum. 2000; 43: 1141-1145
22. Alves A, Panis Y, Bouhnik Y, et al. Risk factors for intra-Abdominal septic complications after a first ileocecal resection for Crohn's disease: a multivariate analysis in 161 consecutive patients. Dis Colon Rectum. 2007; 50: 331-336
23. Huang W, Tang Y, Nong L, et al. Risk factors for postoperative intraabdominal septic complications after surgery in Crohn's disease: a metaanalysis of observational studies. J Crohns Colitis. 2015; 9: 293-301
24. Ramadas AV, Gunesh S, Thomas GA, et al. Natural history of Crohn's disease in a population-based cohort from Cardiff (1986-2003): a study of changes in medical treatment and surgical resection rates. Gut. 2010; 59: 1200-1206
25. Riis A, Martinsen TC, Waldum HL, et al. Clinical experience with infliximab and adalimumab in a single-center cohort of patients with Crohn's disease. Scand J Gastroenterol. 2012; 47: 649-657
26. Agwunobi AO, Carlson GL, Anderson ID, et al. Mechanisms of intestinal failure in Crohn's disease. Dis Colon Rectum. 2001; 44: 1834-1837
27. McIntyre PB, Ritchie JK, Hawley PR, et al. Management of enterocutaneous fistulas: a review of 132 cases. Br J Surg. 1984; 71: 293-296
28. Hollington P, Mawdsley J, Lim W, et al. An 11-year experience of enterocutaneous fistula. Br J Surg. 2004; 91: 1646-1651
29. Datta V, Engledow A, Chan S, et al. The management of enterocutaneous fistula in a regional unit in the United Kingdom: a prospective study. Dis Colon Rectum. 2010; 53: 192-199
30. Lynch AC, Delaney CP, Senagore AJ, et al. Clinical outcome and factors predictive of recurrence after enterocutaneous fistula surgery. Ann Surg. 2004; 240: 825-831
31. Carbonnel F, Cosnes J, Chevret S, et al. The role of anatomic factors in nutritional autonomy after extensive small bowel resection. JPEN J Parenter Enteral Nutr. 1996; 20: 275-280
32. Hofmann AF, Poley JR. Role of bile acid malabsorption in pathogenesis of diarrhea and steatorrhea in patients with ileal resection. I. Response to cholestyramine or replacement of dietary long chain triglyceride by medium chain triglyceride. Gastroenterology. 1972; 62: 918-934
33. Welch IM, Cunningham KM, Read NW. Regulation of gastric emptying by ileal nutrients in humans. Gastroenterology. 1988; 94: 401-404
34. Schmidt T, Pfeiffer A, Hackelsberger N, et al. Effect of intestinal resection on human small bowel motility. Gut. 1996; 38: 859-863
35. Windsor CW, Fejfar J, Woodward DA. Gastric secretion after massive small bowel resection. Gut. 1969; 10: 779-786
36. Toskes PP, Giannella RA, Jervis HR, et al. Small intestinal mucosal injury in the experimental blind loop syndrome. Light- And electronmicroscopic and histochemical studies. Gastroenterology. 1975; 68(5 pt 1): 1193-1203
37. Pomare EW, Branch WJ, Cummings JH. Carbohydrate fermentation in the human colon and its relation to acetate concentrations in venous blood. J Clin Invest. 1985; 75: 1448-1454
38. Nordgaard I, Hansen BS, Mortensen PB. Colon as a digestive organ in patients with short bowel. Lancet. 1994; 343: 373-376
39. Royall D, Wolever TM, Jeejeebhoy KN. Evidence for colonic conservation of malabsorbed carbohydrate in short bowel syndrome. Am J Gastroenterol. 1992; 87: 751-756
40. Tappenden KA. Mechanisms of enteral nutrient-enhanced intestinal adaptation. Gastroenterology. 2006; 130(2 suppl 1): S93-S99
41. Messing B, Colombel JF, Heresbach D, et al. Chronic cholestasis and macronutrient excess in patients treated with prolonged parenteral nutrition. Nutrition. 1992; 8: 30-36
42. Nightingale JM. Hepatobiliary, renal and bone complications of intestinal failure. Best Pract Res Clin Gastroenterol. 2003; 17: 907-929
43. Nolan JP. Intestinal endotoxins as mediators of hepatic injury-An idea whose time has come again. Hepatology. 1989; 10: 887-891
44. Sheldon GF, Peterson SR, Sanders R. Hepatic dysfunction during hyperalimentation. Arch Surg. 1978; 113: 504-508
45. Cavicchi M, Beau P, Crenn P, et al. Prevalence of liver disease and contributing factors in patients receiving home parenteral nutrition for permanent intestinal failure. Ann Intern Med. 2000; 132: 525-532
46. Chan S, McCowen KC, Bistrian BR, et al. Incidence, prognosis, and etiology of end-stage liver disease in patients receiving home total parenteral nutrition. Surgery. 1999; 126: 28-34
47. Nightingale JM, Lennard-Jones JE, Gertner DJ, et al. Colonic preservation reduces need for parenteral therapy, increases incidence of renal stones, but does not change high prevalence of gall stones in patients with a short bowel. Gut. 1992; 33: 1493-1497
48. Crispin A, Thul P, Arnold D, et al. Central venous catheter complications during home parenteral nutrition: a prospective pilot study of 481 patients with more than 30, 000 catheter days. Onkologie. 2008; 31: 605-609
49. Ireton-Jones C, DeLegge M. Home parenteral nutrition registry: a fiveyear retrospective evaluation of outcomes of patients receiving home parenteral nutrition support. Nutrition. 2005; 21: 156-160
50. Reimund JM, Arondel Y, Finck G, et al. Catheter-related infection in patients on home parenteral nutrition: results of a prospective survey. Clin Nutr. 2002; 21: 33-38
51. Davidson JB, Edakkanambeth Varayil J, Okano A, et al. Prevention of subsequent catheter-related bloodstream infection using catheter locks in high-risk patients receiving home parenteral nutrition. JPEN J Parenter Enteral Nutr. [published online ahead of print September 2, 2015].
52. Cohen-Solal M, Baudoin C, Joly F, et al. Osteoporosis in patients on long-Term home parenteral nutrition: a longitudinal study. J Bone Miner Res. 2003; 18: 1989-1994
53. Hurley DL, McMahon MM. Long-Term parenteral nutrition and metabolic bone disease. Endocrinol Metab Clin North Am. 1990; 19: 113-131
54. Pironi L, Labate AM, Pertkiewicz M, et al. Prevalence of bone disease in patients on home parenteral nutrition. Clin Nutr. 2002; 21: 289-296
55. Ferrone M, Geraci M. A review of the relationship between parenteral nutrition and metabolic bone disease. Nutr Clin Pract. 2007; 22: 329-339
56. Vargas JH, Klein GL, Ament ME, et al. Metabolic bone disease of total parenteral nutrition: course after changing from casein to amino acids in parenteral solutions with reduced aluminum content. Am J Clin Nutr. 1988; 48: 1070-1078
57. Compher C, Pazianas M, Benedict S, et al. Systemic inflammatory mediators and bone homeostasis in intestinal failure. JPEN J Parenter Enteral Nutr. 2007; 31: 142-147
58. Saitta JC, Ott SM, Sherrard DJ, et al. Metabolic bone disease in adults receiving long-Term parenteral nutrition: longitudinal study with regional densitometry and bone biopsy. JPEN J Parenter Enteral Nutr. 1993; 17: 214-219
59. Stauffer JQ, Humphreys MH, Weir GJ. Acquired hyperoxaluria with regional enteritis after ileal resection. Role of dietary oxalate. Ann Intern Med. 1973; 79: 383-391
60. Chadwick VS, Modha K, Dowling RH. Mechanism for hyperoxaluria in patients with ileal dysfunction. N Engl J Med. 1973; 289: 172-176
61. Earnest DL, Johnson G, Williams HE, et al. Hyperoxaluria in patients with ileal resection: an abnormality in dietary oxalate absorption. Gastroenterology. 1974; 66: 1114-1122
62. Howard L, Malone M. Current status of home parenteral nutrition in the United States. Transpl Proc. 1996; 28: 2691-2695
63. Messing B, Landais P, Goldfarb B, et al. Home parenteral nutrition for adults. Results of a multicenter survey in France [in French]. Presse Med. 1988; 17: 845-849
64. Silverberg MS, Satsangi J, Ahmad T, et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol. 2005; 19(suppl A): 5A-36A
65. Crenn P, Morin MC, Joly F, et al. Net digestive absorption and adaptive hyperphagia in adult short bowel patients. Gut. 2004; 53: 1279-1286
66. O'Keefe SJ, Buchman AL, Fishbein TM, et al. Short bowel syndrome and intestinal failure: consensus definitions and overview. Clin Gastroenterol Hepatol. 2006; 4: 6-10
67. Lochs H, Dejong C, Hammarqvist F, et al. ESPEN guidelines on enteral nutrition: gastroenterology. Clin Nutr. 2006; 25: 260-274
68. Van Gossum A, Cabre E, Hebuterne X, et al. ESPEN guidelines on parenteral nutrition: gastroenterology. Clin Nutr. 2009; 28: 415-427
69. Joly F, Dray X, Corcos O, et al. Tube feeding improves intestinal absorption in short bowel syndrome patients. Gastroenterology. 2009; 136: 824-831
70. Awouters F, Niemegeers CJ, Janssen PA. Pharmacology of antidiarrheal drugs. Annu Rev Pharmacol Toxicol. 1983; 23: 279-301
71. Awouters F, Megens A, Verlinden M, et al. Survey of studies on mechanism of its antidiarrheal activity. Dig Dis Sci. 1993; 38: 977-995
72. Williams NS, Evans P, King RF. Gastric acid secretion and gastrin production in the short bowel syndrome. Gut. 1985; 26: 914-919
73. Nightingale JM, Walker ER, Farthing MJ, et al. Effect of omeprazole on intestinal output in the short bowel syndrome. Aliment Pharmacol Ther. 1991; 5: 405-412
74. Jeppesen PB, Staun M, Tjellesen L, et al. Effect of intravenous ranitidine and omeprazole on intestinal absorption of water, sodium, and macronutrients in patients with intestinal resection. Gut. 1998; 43: 763-769
75. McDoniel K, Taylor B, Huey W, et al. Use of clonidine to decrease intestinal fluid losses in patients with high-output short-bowel syndrome. JPEN J Parenter Enteral Nutr. 2004; 28: 265-268
76. Nightingale JM, Walker ER, Burnham WR, et al. Octreotide (a somatostatin analogue) improves the quality of life in some patients with a short intestine. Aliment Pharmacol Ther. 1989; 3: 367-373
77. Rodrigues CA, Lennard-Jones JE, Thompson DG, et al. The effects of octreotide, soy polysaccharide, codeine and loperamide on nutrient, fluid and electrolyte absorption in the short-bowel syndrome. Aliment Pharmacol Ther. 1989; 3: 159-169
78. Cooper JC, Williams NS, King RF, et al. Effects of a long-Acting somatostatin analogue in patients with severe ileostomy diarrhoea. Br J Surg. 1986; 73: 128-131
79. Ladefoged K, Christensen KC, Hegnhoj J, et al. Effect of a long acting somatostatin analogue SMS 201-995 on jejunostomy effluents in patients with severe short bowel syndrome. Gut. 1989; 30: 943-949
80. Drucker DJ, Erlich P, Asa SL, et al. Induction of intestinal epithelial proliferation by glucagon-like peptide 2. Proc Natl Acad Sci U S A. 1996; 93: 7911-7916
81. Benjamin MA, McKay DM, Yang PC, et al. Glucagon-like peptide-2 enhances intestinal epithelial barrier function of both transcellular and paracellular pathways in the mouse. Gut. 2000; 47: 112-119
82. Scott RB, Kirk D, MacNaughton WK, et al. GLP-2 augments the adaptive response to massive intestinal resection in rat. Am J Physiol. 1998; 275(5 pt 1): G911-G921
83. Jeppesen PB, Gilroy R, Pertkiewicz M, et al. Randomised placebocontrolled trial of teduglutide in reducing parenteral nutrition and/or intravenous fluid requirements in patients with short bowel syndrome. Gut. 2011; 60: 902-914
84. O'Keefe SJ, Jeppesen PB, Gilroy R, et al. Safety and efficacy of teduglutide after 52 weeks of treatment in patients with short bowel intestinal failure. Clin Gastroenterol Hepatol. 2013; 11: 815-823. e811-813
85. Gu Y, Wu ZH, Xie JX, et al. Effects of growth hormone (rhGH) and glutamine supplemented parenteral nutrition on intestinal adaptation in short bowel rats. Clin Nutr. 2001; 20: 159-166
86. Wales PW, Nasr A, De Silva N, et al. Human growth hormone and glutamine for patients with short bowel syndrome. Cochrane Database Syst Rev. 2010: CD006321
87. Beyer-Berjot L, Joly F, Maggiori L, et al. Segmental reversal of the small bowel can end permanent parenteral nutrition dependency: an experience of 38 adults with short bowel syndrome. Ann Surg. 2012; 256: 739-744; discussion 744-735
88. Glick PL, De Lorimier AA, Adzick NS, et al. Colon interposition: an adjuvant operation for short-gut syndrome. J Pediatr Surg. 1984; 19: 719-725
89. Bianchi A. Longitudinal intestinal lengthening and tailoring: results in 20 children. J R Soc Med. 1997; 90: 429-432
90. Reinshagen K, Kabs C, Wirth H, et al. Long-Term outcome in patients with short bowel syndrome after longitudinal intestinal lengthening and tailoring. J Pediatr Gastroenterol Nutr. 2008; 47: 573-578
91. Kim HB, Fauza D, Garza J, et al. Serial transverse enteroplasty (STEP): a novel bowel lengthening procedure. J Pediatr Surg. 2003; 38: 425-429
92. Jones BA, Hull MA, Potanos KM, et al. Report of 111 consecutive patients enrolled in the International Serial Transverse Enteroplasty (STEP) Data Registry: a retrospective observational study. J Am Coll Surg. 2013; 216: 438-446
93. Modi BP, Javid PJ, Jaksic T, et al. First report of the international serial transverse enteroplasty data registry: indications, efficacy, and complications. J Am Coll Surg. 2007; 204: 365-371
94. Grant D, Abu-Elmagd K, Mazariegos G, et al. Intestinal transplant registry report: global activity and trends. Am J Transpl. 2015; 15: 210-219
95. Smith JM, Skeans MA, Horslen SP, et al. OPTN/SRTR 2013 annual data report: intestine. Am J Transpl. 2015; 15(suppl 2): 1-16
96. Kaufman SS, Atkinson JB, Bianchi A, et al. Indications for pediatric intestinal transplantation: a position paper of the American Society of Transplantation. Pediatr Transpl. 2001; 5: 80-87
97. Harpaz N, Schiano T, Ruf AE, et al. Early and frequent histological recurrence of Crohn's disease in small intestinal allografts. Transplantation. 2005; 80: 1667-1670
98. Koritsky DCG, Bond G, Shcuster B, et al. Intestinal transplantation for end stage Crohn's disease: therapeutic efficacy and disease recurrence. Inflamm Bowel Dis. 2012; 18: S3
99. Sustento-Reodica N, Ruiz P, Rogers A, et al. Recurrent Crohn's disease in transplanted bowel. Lancet. 1997; 349: 688-691
100. Kaila B, Grant D, Pettigrew N, et al. Crohn's disease recurrence in a small bowel transplant. Am J Gastroenterol. 2004; 99: 158-162